Completed PHASE4 INTERVENTIONAL 1-arm NCT02248506

Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis.

Sponsor: Gynea Laboratorios SA

Conditions Candidiasis, Vulvovaginal

Interventions Clotrimazole

Updated 6 times since 2017 Last updated: Mar 24, 2015 Started: Jun 30, 2013 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Candidiasis, Vulvovaginal and is currently completed. Gynea Laboratorios SA leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Dec 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gynea Laboratorios SA
Instituto Palacios

Data source: Instituto Palacios

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain